-
Butylated Hydroxyanisole (BHA) in Redox Assays
2026-09-01
Butylated hydroxyanisole (BHA) is a practical redox perturbation tool for separating oxidative chemistry from assay artifacts. This guide shows how to prepare fresh solutions, design ROS and cell-protection controls, and translate peptide-receptor lessons into more reliable oxidative stress research.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-01
Use dual Cy5 and EGFP readouts to distinguish mRNA delivery from productive translation in mammalian cells. This workflow shows how to benchmark carriers, investigate macrophage uptake, and troubleshoot poor expression with a 5-methoxyuridine modified mRNA control.
-
PBS (Phosphate-Buffered Saline) Workflow Guide
2026-08-31
PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, isotonic buffer for cell washing, reagent dilution, and compatible routine assay steps that require controlled pH and osmolarity. It is intended for in vitro scientific research only and should not replace culture medium or validated diagnostic, clinical, or assay-specific buffers without compatibility testing.
-
Thymoquinone Protects Against Doxorubicin Cardiotoxicity
2026-08-31
The reference study reports that thymoquinone protects mice from doxorubicin-associated cardiac injury while improving antioxidant defenses and ferroptosis-related molecular signals. Its value lies in linking functional cardiac protection to the Nrf2/HO-1 pathway, although the findings remain preclinical and require validation in tumor-bearing and clinical models.
-
Degarelix Acetate: From Binding to Biology
2026-08-30
Degarelix acetate is a selective GnRH receptor antagonist whose value extends beyond testosterone suppression. This article presents a layered assay strategy that connects competitive receptor binding with pituitary hormone regulation, prostate cancer research, and translational interpretation.
-
Peptidisc-Assisted Nanobody Clustering
2026-08-29
Chen and Duong van Hoa describe a peptidisc-assisted strategy for clustering nanobodies through hydrophobic interactions rather than tandem genetic linking or conventional cross-linking. The resulting multimeric and multispecific assemblies improved functional avidity and enabled bispecific and autofluorescent nanobody constructs, although the preprint requires further validation of assembly uniformity, mechanism, and broader transferability.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-28
FITC-Concanavalin A (ConA) Conjugate provides a fluorescent lectin probe for visualizing accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids. It is suited to cell surface carbohydrate detection, immunofluorescence staining, tissue labeling, and flow cytometry, but it should not be treated as a universal glycan marker or used for non-carbohydrate targets.
-
Standardized Whole-Blood Immunometabolism with Etomoxir
2026-08-28
Zhao and colleagues present a standardized fresh whole-blood stimulation protocol that combines defined immune challenges with pharmacological modulation of cellular metabolism. The workflow offers a reproducible way to compare cytokine responses across metabolic conditions and provides a practical framework for fatty acid oxidation pathway research without relying exclusively on purified immune-cell systems.
-
Imatinib (STI571) in NET-Aware CML Research
2026-08-27
Imatinib and STI571 provide a precise way to interrogate Abl, PDGF receptor, and c-Kit signaling in CML models. This article develops a NET-aware assay strategy that separates BCR-ABL1 pathway inhibition from broader neutrophil and tyrosine kinase inhibitor effects.
-
EPI-001: Rethinking AR N-Terminal Inhibition
2026-08-27
EPI-001 offers a mechanistically distinct way to interrogate androgen receptor signaling by targeting the receptor’s N-terminal domain. This thought-leadership article connects CRPC biology with emerging AR/ARv7 evidence in TNBC and provides practical guidance for building translationally credible workflows.
-
CX-5461: From Pol I Stress to Mitotic Failure
2026-08-26
CX-5461 is an RNA polymerase I inhibitor that links ribosome biogenesis stress with DNA damage, senescence, autophagy, and mitotic catastrophe. This article provides a mechanistic framework for selecting assays and interpreting solid-tumor responses beyond a simple viability endpoint.
-
Tobramycin for Reliable Cell Assays
2026-08-26
Learn how Tobramycin (SKU B1856) can be integrated into bacterial, co-culture, and cell-based assay workflows without confusing antimicrobial activity with mammalian cytotoxicity. This scenario-driven guide covers formulation, controls, protocol parameters, data interpretation, and practical reagent selection.
-
Ibuprofen in Cell Viability Assays: A8446 Guide
2026-08-25
Learn how Ibuprofen (SKU A8446) can support reproducible cell viability, proliferation, and cytotoxicity workflows through controlled dosing, solvent matching, and orthogonal readouts. The guide connects COX inhibition and anti-proliferative evidence with practical assay design and vendor-selection criteria.
-
CFDA-SE Workflows for Proliferation and Migration
2026-08-25
CFDA-SE converts intracellular esterase activity into a division-sensitive fluorescence signal for lymphocytes, fibroblasts, NK cells, bacteria, and migration models. This practical guide links staining design, flow cytometry controls, and troubleshooting with the CD38 surfaceome findings from nanobody-targeted TurboID.
-
BHQ: A Translational Lens on SERCA and HSC Mobilization
2026-08-24
A mechanistic and translational analysis of 2,5-di-tert-butylbenzene-1,4-diol (BHQ) as a SERCA perturbation tool, integrating calcium homeostasis, ER stress, vascular physiology, and emerging evidence for hematopoietic stem cell mobilization.